Thoracic Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Via G Venezian 1, 20133, Milan, Italy.
Updates Surg. 2024 Apr;76(2):641-646. doi: 10.1007/s13304-023-01700-7. Epub 2023 Nov 25.
Reducing morbidity, length of hospital stay, and readmission rate are of paramount importance to improve patients' care. In the present paper, we aim to describe our experience in managing major oncologic thoracic surgery in clinical practice. This is a retrospective experience over the last 7 years. Data from 215 consecutive patients (performed by a single-team of two surgeon) undergoing thoracic surgery were reviewed and evaluated. The total hospital mean stay was 3,3 days. Complications were represented by 4 hemothorax, 1 pleural empyema without fistula, 3 arrhythmias (atrial fibrillation), 2 pnuemonias and 1 chylotorax. No 30-day severe surgery-related complication occurred, no mortality. In 169 Vats procedures, no convertion was necessary. We conclude that a united team work represented by two close-knit surgeons, with similar clinical background, propensity to share problems, no competitive behavior, allow to do faster surgery, to standardize the procedure improving the post-operative outcomes of cancer patients.
降低发病率、住院时间和再入院率对于改善患者的治疗至关重要。在本文中，我们旨在描述我们在临床实践中管理重大胸外科肿瘤手术的经验。这是过去 7 年的回顾性经验。对 215 名连续患者（由两位外科医生组成的单一团队进行手术）的数据进行了回顾和评估。总的平均住院时间为 3.3 天。并发症包括 4 例血胸、1 例无瘘胸膜积脓、3 例心律失常（心房颤动）、2 例肺炎和 1 例乳糜胸。无 30 天严重手术相关并发症，无死亡。在 169 例 Vats 手术中，无需转换。我们得出结论，由两位紧密合作的外科医生组成的统一团队合作，具有相似的临床背景、分享问题的倾向、没有竞争行为，可以更快地进行手术，使手术标准化，从而提高癌症患者的术后效果。
